Clinical features of thrombosis and bleeding in COVID-19
MR Thomas, M Scully - Blood, The Journal of the American …, 2022 - ashpublications.org
Infection with the SARS-CoV-2 virus, resulting in COVID-19 disease, has presented a
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …
unique scenario associated with high rates of thrombosis. The risk of venous thrombosis is …
Current effective therapeutics in management of COVID-19
K Atluri, I Aimlin, S Arora - Journal of Clinical Medicine, 2022 - mdpi.com
The current pandemic due to the SARS-CoV-2 virus has caused irreparable damage
globally. High importance is placed on defining current therapeutics for Coronavirus …
globally. High importance is placed on defining current therapeutics for Coronavirus …
[HTML][HTML] ISTH guidelines for antithrombotic treatment in COVID‐19
S Schulman, M Sholzberg, AC Spyropoulos… - Journal of Thrombosis …, 2022 - Elsevier
Antithrombotic agents reduce risk of thromboembolism in severely ill patients. Patients with
coronavirus disease 2019 (COVID‐19) may realize additional benefits from heparins …
coronavirus disease 2019 (COVID‐19) may realize additional benefits from heparins …
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of …
Abstract Background: COVID-19–related acute illness is associated with an increased risk of
venous thromboembolism (VTE). Objective: These evidence-based guidelines from the …
venous thromboembolism (VTE). Objective: These evidence-based guidelines from the …
Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial
Background COVID-19 is a viral prothrombotic respiratory infection. Heparins exert
antithrombotic and anti-inflammatory effects, and might have antiviral properties. We aimed …
antithrombotic and anti-inflammatory effects, and might have antiviral properties. We aimed …
COVID-19-associated pulmonary embolism: review of the pathophysiology, epidemiology, prevention, diagnosis, and treatment
L Ortega-Paz, AH Talasaz… - … in thrombosis and …, 2022 - thieme-connect.com
COVID-19 is associated with endothelial activation in the setting of a potent inflammatory
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …
reaction and a hypercoagulable state. The end result of this thromboinflammatory state is an …
Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients: a meta-analysis of multicenter randomized controlled trials
E Pilia, A Belletti, S Fresilli, G Finco… - Journal of Thrombosis and …, 2022 - Springer
Arterial and venous thrombotic events in COVID-19 cause significant morbidity and mortality
among patients. Although international guidelines agree on the need for anticoagulation, it …
among patients. Although international guidelines agree on the need for anticoagulation, it …
Effects of standard-dose prophylactic, high-dose prophylactic, and therapeutic anticoagulation in patients with hypoxemic COVID-19 pneumonia: the ANTICOVID …
Importance Given the high risk of thrombosis and anticoagulation-related bleeding in
patients with hypoxemic COVID-19 pneumonia, identifying the lowest effective dose of …
patients with hypoxemic COVID-19 pneumonia, identifying the lowest effective dose of …
The diverse role of heparan sulfate and other GAGs in SARS-CoV-2 infections and therapeutics
In December 2019, the global coronavirus disease 2019 (COVID-19) pandemic began in
Wuhan, China. COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 …
Wuhan, China. COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 …
[HTML][HTML] Deaths related to pulmonary embolism and cardiovascular events before and during the 2020 COVID-19 pandemic: An epidemiological analysis of data from …
Background Pulmonary embolism is a known complication of coronavirus disease 2019
(COVID-19). Epidemiological population data focusing on pulmonary embolism-related …
(COVID-19). Epidemiological population data focusing on pulmonary embolism-related …